EXCLUSIVE: Ampio Pharma Reports Top-Line Results From Study Evaluating Efficacy Of Intra-Articular Injection Of Ampion In Adults With Pain Due To Severe Osteoarthritis Of The Knee: Showed Statistically Significant Reduction In Pain At 12 Weeks